Page last updated: 2024-09-03

thrombin receptor peptide sfllrnp and Atrial Fibrillation

thrombin receptor peptide sfllrnp has been researched along with Atrial Fibrillation in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bisping, E; Cvirn, G; Gallistl, S; Gaugler, J; Haidl, H; Jasser-Nitsche, H; Pohl, S; Schlagenhauf, A; Schwinger, W1
Ivankova, J; Kovar, F; Mokan, M; Nehaj, F; Sokol, J; Stasko, J1

Trials

1 trial(s) available for thrombin receptor peptide sfllrnp and Atrial Fibrillation

ArticleYear
First Evidence: TRAP-Induced Platelet Aggregation Is Reduced in Patients Receiving Xabans.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2018, Volume: 24, Issue:6

    Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Female; Humans; Male; Middle Aged; Peptide Fragments; Platelet Aggregation; Platelet Function Tests; Pyrazoles; Pyridones; Rivaroxaban; Time Factors

2018

Other Studies

1 other study(ies) available for thrombin receptor peptide sfllrnp and Atrial Fibrillation

ArticleYear
Impact of electric cardioversion on platelet activation.
    PloS one, 2021, Volume: 16, Issue:4

    Topics: Adenosine Diphosphate; Adult; Aged; Arachidonic Acid; Atrial Fibrillation; Blood Coagulation; Collagen; Electric Countershock; Female; Humans; Male; Middle Aged; Peptide Fragments; Platelet Activation; Platelet Aggregation; Platelet Factor 4; Platelet Function Tests; Ristocetin; Treatment Outcome

2021